Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narendra Chirmule

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Immunological Methods|February 2, 2006
A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheresSonela A Schlottmann, Neil Jain, Narendra Chirmule, et al.
Journal of Biosciences|November 27, 2025
Brain dystrophinopathies and cognitive impairment: Pathogenesis, diagnosis, and therapiesAadi Saluja, Kyriloss Gad, Phillipa Iyede, et al.
Journal of Biosciences|February 2, 2026
Correction to: Brain dystrophinopathies and cognitive impairment: Pathogenesis, diagnosis, and therapiesAadi Saluja, Kyriloss Gad, Phillipa Iyede, et al.
Surgery|April 28, 2005
Macrophage ablation attenuates adenoviral vector-induced pancreatitisAlexander L Shifrin, Narendra Chirmule, Yi Zhang, et al.
Human Gene Therapy|October 25, 2002
PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liverMaria A Croyle, Narendra Chirmule, Yi Zhang, et al.
Clinical Pharmacology and Therapeutics|October 6, 2022
On the Manufacturers of Biosimilars in AsiaSmritie Sheth, Laxmikant Vashishta, Rohit Goyal, et al.
Frontiers in Immunology|April 17, 2023
A four-part guide to lung immunology: Invasion, inflammation, immunity, and interventionIndiwari Gopallawa, Ruchika Dehinwal, Vaibhav Bhatia, et al.
Frontiers in Immunology|May 30, 2023
Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics developmentZuben E Sauna, Vibha Jawa, Sathy Balu-Iyer, et al.
Cytotherapy|November 10, 2021
CAR-T cell therapy in India requires a paradigm shift in training, education and health care processesAkshay Ravindranath, Aparajita Dubey, Surekha Suresh, et al.
Journal of Pharmaceutical Sciences|March 19, 2026
A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoringIndiwari Gopallawa, Surendra Chavan, Arvind Goswami, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Immunological Methods|February 2, 2006
A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheresSonela A Schlottmann, Neil Jain, Narendra Chirmule, et al.
Journal of Biosciences|November 27, 2025
Brain dystrophinopathies and cognitive impairment: Pathogenesis, diagnosis, and therapiesAadi Saluja, Kyriloss Gad, Phillipa Iyede, et al.
Journal of Biosciences|February 2, 2026
Correction to: Brain dystrophinopathies and cognitive impairment: Pathogenesis, diagnosis, and therapiesAadi Saluja, Kyriloss Gad, Phillipa Iyede, et al.
Surgery|April 28, 2005
Macrophage ablation attenuates adenoviral vector-induced pancreatitisAlexander L Shifrin, Narendra Chirmule, Yi Zhang, et al.
Human Gene Therapy|October 25, 2002
PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liverMaria A Croyle, Narendra Chirmule, Yi Zhang, et al.
Clinical Pharmacology and Therapeutics|October 6, 2022
On the Manufacturers of Biosimilars in AsiaSmritie Sheth, Laxmikant Vashishta, Rohit Goyal, et al.
Frontiers in Immunology|April 17, 2023
A four-part guide to lung immunology: Invasion, inflammation, immunity, and interventionIndiwari Gopallawa, Ruchika Dehinwal, Vaibhav Bhatia, et al.
Frontiers in Immunology|May 30, 2023
Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics developmentZuben E Sauna, Vibha Jawa, Sathy Balu-Iyer, et al.
Cytotherapy|November 10, 2021
CAR-T cell therapy in India requires a paradigm shift in training, education and health care processesAkshay Ravindranath, Aparajita Dubey, Surekha Suresh, et al.
Journal of Pharmaceutical Sciences|March 19, 2026
A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoringIndiwari Gopallawa, Surendra Chavan, Arvind Goswami, et al.
Pageof 6